INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$3.5M

$3,496,925

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
RAPP S Rapport Therapeutics, Inc. Ceesay Abraham • CEO 10b5-1 Sell 2026-02-18 $320,373x4 View Form 4 →
RAPP	Rapport Therapeutics, Inc.	Ceesay Abraham CEO 10b5-1 Sell	2026-02-18	$320,373x4	S	Form 4
RAPP S Rapport Therapeutics, Inc. Ceesay Abraham • CEO 10b5-1 Sell 2026-01-20 $285,071x2 View Form 4 →
RAPP	Rapport Therapeutics, Inc.	Ceesay Abraham CEO 10b5-1 Sell	2026-01-20	$285,071x2	S	Form 4
RAPP S Rapport Therapeutics, Inc. Ceesay Abraham • CEO 10b5-1 Sell 2025-12-17 $323,508x6 View Form 4 →
RAPP	Rapport Therapeutics, Inc.	Ceesay Abraham CEO 10b5-1 Sell	2025-12-17	$323,508x6	S	Form 4
RAPP S Rapport Therapeutics, Inc. Ceesay Abraham • CEO 10b5-1 Sell 2025-11-17 $275,047x4 View Form 4 →
RAPP	Rapport Therapeutics, Inc.	Ceesay Abraham CEO 10b5-1 Sell	2025-11-17	$275,047x4	S	Form 4
RAPP S Rapport Therapeutics, Inc. Ceesay Abraham • CEO 10b5-1 Sell 2025-10-15 $281,729x4 View Form 4 →
RAPP	Rapport Therapeutics, Inc.	Ceesay Abraham CEO 10b5-1 Sell	2025-10-15	$281,729x4	S	Form 4
RAPP S Rapport Therapeutics, Inc. Ceesay Abraham • CEO 10b5-1 Sell 2025-09-17 $2,011,197Largex4 View Form 4 →
RAPP	Rapport Therapeutics, Inc.	Ceesay Abraham CEO 10b5-1 Sell	2025-09-17	$2,011,197Largex4	S	Form 4